AbbVie Inc.
AbbVie
ABBV · NYSE
Healthcare
Catalog as of September 15, 2026. Not a live market feed.
- Fiscal Year
- 2025
- Revenue
- $61.2B
- Assets
- $134B
- SEC filing
- DEF 14A
- Filed
- March 23, 2026
Executive Compensation
Compensation reported for AbbVie’s named executive officers, including salary, stock awards, incentive compensation, other compensation, and total compensation.
Robert A. Michael
Chairman Of The Board And Chief Executive Officer
$32.5M
Reported total
- Salary
- $1,700,000
- Stock awards
- $13,268,456
- Incentives
- $5,200,000
- Option awards
- $3,199,154
- Other
- $9,163,374
Jeffrey R. Stewart
Executive Vice President, Chief Commercial Officer
$15.4M
Reported total
- Salary
- $1,315,726
- Stock awards
- $5,390,310
- Incentives
- $2,950,000
- Option awards
- $1,299,655
- Other
- $4,479,613
Scott T. Reents
Executive Vice President, Chief Financial Officer
$12.4M
Reported total
- Salary
- $1,124,116
- Stock awards
- $4,353,512
- Incentives
- $2,350,000
- Option awards
- $1,049,698
- Other
- $3,475,676
Azita Saleki-Gerhardt
Executive Vice President, Chief Operations Officer
$10.8M
Reported total
- Salary
- $1,052,581
- Stock awards
- $3,980,457
- Incentives
- $2,200,000
- Option awards
- $959,750
- Other
- $2,599,188
Roopal B. Thakkar
Executive Vice President, Chief Scientific Officer
$9.9M
Reported total
- Salary
- $1,146,154
- Stock awards
- $3,980,457
- Incentives
- $2,350,000
- Option awards
- $959,750
- Other
- $1,476,482
Robert A. Michael
Chairman Of The Board And Chief Executive Officer
$32.5M
Reported total · FY2025 · SCT Total as filed
Source: DEF 14A Summary Compensation Table, filed March 23, 2026.
- Salary
- $1.7M
- Stock Awards
- $13.3M
- Option Awards
- $3.2M
- Incentives
- $5.2M
- Other
- $9.2M
Historical Compensation
Robert A. Michael total compensation, fiscal years 2023–2025.
| Fiscal Year | Salary | Stock Awards | Total Compensation |
|---|---|---|---|
| 2025 | $1,700,000 | $13,268,456 | $32,530,984 |
| 2024 | $1,607,404 | $7,915,762 | $18,492,517 |
| 2023 | $1,427,376 | $5,440,297 | $14,441,320 |
Named Executive Officers
Robert A. Michael
Chairman Of The Board And Chief Executive Officer
AbbVie · ABBV
$32.5M
FY 2025 · DEF 14A
Scott T. Reents
Executive Vice President, Chief Financial Officer
AbbVie · ABBV
$12.4M
FY 2025 · DEF 14A
Jeffrey R. Stewart
Executive Vice President, Chief Commercial Officer
AbbVie · ABBV
$15.4M
FY 2025 · DEF 14A
Azita Saleki-Gerhardt
Executive Vice President, Chief Operations Officer
AbbVie · ABBV
$10.8M
FY 2025 · DEF 14A
Roopal B. Thakkar
Executive Vice President, Chief Scientific Officer
AbbVie · ABBV
$9.9M
FY 2025 · DEF 14A
Source information
- Company
- AbbVie Inc.
- Ticker
- ABBV · NYSE
- Filing type
- DEF 14A
- Fiscal year
- 2025
- Filing date
- March 23, 2026
- SEC accession number
- 0001104659-26-033387
Source: U.S. Securities and Exchange Commission, DEF 14A Summary Compensation Table. View SEC filing
Related Companies
Johnson & Johnson
JNJ · NYSE
Joaquin Duato
Chairman/CEO
$32.8M
FY 2025 reported total
View company →
UnitedHealth
UnitedHealth Group Incorporated
UNH · NYSE
Stephen Hemsley
Chief Executive Officer
$60.9M
FY 2025 reported total
View company →
Abbott
Abbott Laboratories
ABT · NYSE
Robert B. Ford
Chairman Of The Board And Chief Executive Officer
$24.2M
FY 2025 reported total
View company →
Align Technology
Align Technology Inc
ALGN · NASDAQ
Joseph M. Hogan
President And Chief Executive Officer
$19.2M
FY 2025 reported total
View company →